Globacure

Piplines

Infectious

Neglected Tropical and Parasitic Infectious Diseases

  • Plasmodium vivax Malaria: Advancing clinical development for a radical cure that ensures safety in G6PD-deficient populations.
  • Malaria Prevention: Developing clinical strategies to prevent transmission of Plasmodium falciparum and Plasmodium vivax.
  • Drug-Resistant Visceral Leishmaniasis: Focusing on oral treatment options in preclinical development.
  • Pneumocystis Pneumonia (PCP): Engaging in preclinical development for innovative treatment options.
  • Tuberculosis Treatment: Pursuing leads for oral treatment options for Mycobacterium Tuberculosis.
  • Human Babesiosis: Developing an oral treatment lead to address this parasitic disease.

Diseases

Neurological Diseases

Selective Natural Product Inhibitors

Exploring natural products that inhibit Human Monoamine Oxidase A and B in preclinical development.

Neurotropic Agents

small molecule agents that mimic neurotrophic factors

Natural Products for Neuroprotection

Advancing formulations aimed at protecting against neurodegenerative processes in preclinical stages.